IT Software Products company Quick Heal Technologies announced Q4FY25 results Revenue: Rs 65.1 crore compared to Rs 80.0 crore during Q4FY24. EBITDA: Rs -8.5 crore compared to Rs 10.0 crore during Q4FY24. EBITDA margin: -13% for Q4FY25. PAT: Rs -3.3 crore compared to Rs 14.0 crore during Q4FY24. PAT margin: -5% for Q4FY25. Vishal Salvi, Chief Executive Officer, Quick Heal Technologies, said: “I am excited to launch our version of Generative AI, SIA, to enable simplified security for our product stack. The successful launches of Seqrite Intelligent Assistant (SIA) and Seqrite Malware Analysis Platform (SMAP) have established new revenue streams, while our Threat Intelligence solution secured its first major enterprise order. The Quick Heal Academy continues to serve as a strategic entry point for large corporates and universities, with five new customer order signed this quarter. Our revamped sales organization is now positioned to execute complex cybersecurity projects at scale. We have been tirelessly working towards strategic project wins from the government and it gives me immense pleasure to state that we have closed a large deal.” Ankit Maheshwari, Chief Financial Officer, Quick Heal Technologies, said: “Growth has been subdued on account of deferred government deals and headwinds in consumer business. While the DPDP Act deferral has temporarily impacted regulatory-driven demand, our Data Privacy Suite remains marketready. We continue to invest heavily in R&D; because that is the core DNA of the cybersecurity business. We have launched multiple products through the year in the Horizon-3 category as we had committed. Following prudent accounting principles, we expense all the R&D; investments in the P&L.; We are fueling our Sales motion through investments in people, channels and marketing events. As we continue to launch new products, our momentum on order book and deferred revenue remains strong. We are committed to lasting shareholder value creation through right investments in the business at the right time.” Result PDF
IT Software Products company Quick Heal Technologies announced Q3FY25 results Revenue: Rs 70.6 crore for Q3FY25. EBITDA: -3.8 crore for Q3FY25. EBITDA Margin: -5.3% for Q3FY25. PAT: Rs 0.1 crore for Q3FY25. PAT margin: 0.2% for Q3FY25. Vishal Salvi, Chief Executive Officer, Quick Heal Technologies, said: “We are starting to witness successful execution of our strategic initiatives and the growing momentum in our new product pipeline. The Pan-India market launch of AntiFraud.AI, coupled with the introduction of our Annual Threat Report at the AISS event, demonstrates our thought leadership in the cybersecurity domain. Additionally, the launch of SMAP (Seqrite Malware Analysis platform) and Threat Intelligence (TI) solutions, along with the first order for TI, reflects our ability to address evolving customer needs. With the recent release of the draft DPDP provisions, we are witnessing a surge in interest as our Seqrite Data Privacy products are well-positioned to capitalize on the new regulations. Our focus on innovation and strategic hirings in mid-management positions us well for sustained growth, as we continue to deliver cutting-edge cybersecurity solutions.” Ankit Maheshwari, Chief Financial Officer, Quick Heal Technologies, said: “We have witnessed headwinds in the Consumer business and Government vertical resulting in muted performance in the quarter. We have made conscious investments in the Horizon-3 product launches and the marketing launch of AntiFraud product. I am happy to state that we have launched the new product in the Horizon-3 category as we had committed. While it might have impacted the profitability in the short term, which is Q3, these are long-term investments made towards our growth journey for the future. We are experiencing structural shift in our business, with a growing confirmed order book standing at 7.18 crore as against 35 lacs at the end of Q2. We remain committed to balancing innovation with financial prudence, ensuring long-term value creation for our stakeholders.” Result PDF
Conference Call with Quick Heal Technologies Ltd. Management and Analysts on Q2FY25 Performance and Outlook. Listen to the full earnings transcript.